Skip to content

PaTIO study : PhysiotherApeutic Treat-to-target Intervention after Orthopaedic surgery; A cost-effectiveness study.

PaTIO study : PhysiotherApeutic Treat-to-target Intervention after Orthopaedic surgery; A cost-effectiveness study. - PATIO study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55756
Enrollment
624
Registered
2017-12-20
Start date
2018-08-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip and knee replacement

Interventions

Treat-to-target: optimized, personalized strategy implying that after receiving PT in the postoperative phase in the hospital will either or not be referred to primary care PT based on a standardized

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients eligible for this trial are patients with clinical and radiological knee or hip OA who are scheduled for a primary TKA or THA, and willing to comply with the study protocol.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: TKA or THA for a diagnosis other than OA, uncontrolled cardiovascular disease or hypertension, history of neuromuscular disorder that affects lower extremity function, terminal illness, plans to have another joint replacement during study follow-up, not able to attend follow-up measurements, not able to attend the PPT in primary setting, serious adverse events during surgery or directly thereafter, serious psychiatric disorders, or insufficient command of the Dutch language, spoken and/or written.

Design outcomes

Primary

MeasureTime frame
Difference between both groups regarding changes of KOOS-PS/HOOS-PS, a measure of physical functioning, between baseline and 3 months postoperatively. Differences between both groups regarding cost-effectiveness.

Secondary

MeasureTime frame
Differences between both groups in: - recovery of function during 12 months follow-up, - in scores of OKS/OHS (functioning), NRS (amount of pain), EQ-5D (quality of life), performance tests, physical activity level, and satisfaction of the patient.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026